Pei, Y., Liu, J., Cheng, J., Wu, W., & Liu, X. (2019). Silencing of LAMC2 Reverses Epithelial-Mesenchymal Transition and Inhibits Angiogenesis in Cholangiocarcinoma via Inactivation of the Epidermal Growth Factor Receptor Signaling Pathway. The American journal of pathology, 189(8), 1637. https://doi.org/10.1016/j.ajpath.2019.03.012
Citace podle Chicago (17th ed.)Pei, Yao-Fei, Jie Liu, Jian Cheng, Wei-Ding Wu, a Xi-Qiang Liu. "Silencing of LAMC2 Reverses Epithelial-Mesenchymal Transition and Inhibits Angiogenesis in Cholangiocarcinoma via Inactivation of the Epidermal Growth Factor Receptor Signaling Pathway." The American Journal of Pathology 189, no. 8 (2019): 1637. https://doi.org/10.1016/j.ajpath.2019.03.012.
Citace podle MLA (9th ed.)Pei, Yao-Fei, et al. "Silencing of LAMC2 Reverses Epithelial-Mesenchymal Transition and Inhibits Angiogenesis in Cholangiocarcinoma via Inactivation of the Epidermal Growth Factor Receptor Signaling Pathway." The American Journal of Pathology, vol. 189, no. 8, 2019, p. 1637, https://doi.org/10.1016/j.ajpath.2019.03.012.